Related Experiment Video
Updated: Dec 15, 2025

Author Spotlight: Diatom Testing for Forensic Drowning Examination
Published on: November 10, 2023
Anticancer Compounds Derived from Marine Diatoms
Hanaa Ali Hussein1,2, Mohd Azmuddin Abdullah1
1Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Nerus 21030, Terengganu, Malaysia.
Diatoms, rich in bioactive compounds, show potent anti-cancer properties. Their unique biosilica structure offers a safe and effective nanocarrier for targeted cancer drug delivery.
Area of Science:
- Marine Biology
- Biotechnology
- Nanomedicine
Background:
- Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies.
- Diatoms are unicellular algae abundant in minerals and bioactive compounds with demonstrated anti-cancer, anti-oxidant, and anti-bacterial activities.
- Diatoms play a crucial role in biogeochemical cycles due to their rapid growth and high yield.
Purpose of the Study:
- To review the anti-cancer activities of diatoms.
- To explore the potential of diatoms and their biosilica as drug delivery systems for cancer therapy.
- To discuss the use of diatoms as carriers for antibodies and vitamin B12 in drug delivery.
Main Methods:
- Literature review of studies on diatom bioactivity and applications in cancer therapy.
- Analysis of diatom biosilica properties relevant to drug delivery (surface area, porosity, biocompatibility).
- Examination of in vivo studies assessing the safety of diatom-based nanocarriers.
Main Results:
- Diatoms possess bioactive compounds with significant anti-cancer potential.
- Diatom biosilica exhibits favorable characteristics for nanocarrier applications, including high surface area, nano-porosity, and biocompatibility.
- In vivo studies indicate no significant tissue damage, supporting the safety of diatom-based nanocarriers.
Conclusions:
- Diatoms represent a promising source of anti-cancer agents.
- Diatom biosilica is a viable and safe nanocarrier for targeted delivery of anti-cancer drugs.
- Diatom-based systems, including antibody and vitamin B12 conjugates, hold potential in nanomedicine for cancer treatment.
More Related Videos
11:28Isolating and Incorporating Light-Harvesting Antennas from Diatom Cyclotella Meneghiniana in Liposomes with Thylakoid Lipids
Published on: August 28, 2018
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Other Algae
Targeted Cancer Therapies
There are several types of targeted therapies against...
Diversity of Protists II